Sobre 6 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Browse the full record of transactions filed by EcoR1 Capital, LLC. Officer active across 12 companies, notably First Tracks Biotherapeutics, Inc.. Aggregated, 59 disclosures have been published. Breakdown: 36 buys · 13 sells. Total volume traded: €289.5m. Activity tracked since 30 April 2021. The latest transaction was disclosed on 20 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to EcoR1 Capital, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1.142.857 títulos@ 17,50 US$25.2% de su flujoCommon StockSEC:0000895345-24-000172:0
25 de 59 declaraciones
About EcoR1 Capital, LLC
EcoR1 Capital, LLC is a declarant associated with the listed companies, with director roles at Zymeworks Inc., Anaptysbio, INC and AKTIS ONCOLOGY, INC. Across the 38 filings, the 38 sampled filings cover the period from 2021-05-04 to 2026-04-22, with EUR 128347075 in buys and EUR 103843311 in sells, and the modal transaction nature is Acquisition.